Michael Rosu-Myles
Overview
Explore the profile of Michael Rosu-Myles including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
781
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamming L, Duque D, Tran A, Lansdell C, Frahm G, Wu J, et al.
Mol Ther Methods Clin Dev
. 2025 Jan;
33(1):101388.
PMID: 39759470
[This corrects the article DOI: 10.1016/j.omtm.2024.101325.].
2.
Zhang W, Sloan A, Prevost J, Tamming L, Raman S, Pfeifle A, et al.
Emerg Microbes Infect
. 2024 Nov;
13(1):2427792.
PMID: 39508450
The nucleoprotein (NP) of type A influenza virus (IAV) is highly conserved across all virus strains, making it an attractive candidate antigen for universal vaccines. While various studies have explored...
3.
Tamming L, Duque D, Bavananthasivam J, Tran A, Lansdell C, Frahm G, et al.
Mol Ther Methods Clin Dev
. 2024 Sep;
32(3):101325.
PMID: 39309757
The effectiveness of mRNA vaccines largely depends on their lipid nanoparticle (LNP) component. Herein, we investigate the effectiveness of DLin-KC2-DMA (KC2) and SM-102-based LNPs for the intramuscular delivery of a...
4.
Pfeifle A, Zhang W, Cao J, Thulasi Raman S, Anderson-Duvall R, Tamming L, et al.
Emerg Microbes Infect
. 2024 Sep;
13(1):2399949.
PMID: 39221484
The rising prevalence of Lyme disease (LD) in North America and Europe has emerged as a pressing public health concern. Despite the availability of veterinary LD vaccines, no vaccine is...
5.
Zhang W, Pfeifle A, Lansdell C, Frahm G, Cecillon J, Tamming L, et al.
Vaccines (Basel)
. 2023 Oct;
11(10).
PMID: 37896985
In recent years, lipid nanoparticles (LNPs) have emerged as a revolutionary technology for vaccine delivery. LNPs serve as an integral component of mRNA vaccines by protecting and transporting the mRNA...
6.
Pfeifle A, Thulasi Raman S, Lansdell C, Zhang W, Tamming L, Cecillon J, et al.
Front Immunol
. 2023 Apr;
14:1020134.
PMID: 37006299
Introduction: The incidence of Lyme disease (LD) in Canada and the United States has risen over the last decade, nearing 480,000 cases each year. sensu lato, the causative agent of...
7.
Thulasi Raman S, Zetner A, Hashem A, Patel D, Wu J, Gravel C, et al.
Emerg Microbes Infect
. 2023 Mar;
12(1):2192821.
PMID: 36927227
Influenza and Respiratory Syncytial virus (RSV) infections together contribute significantly to the burden of acute lower respiratory tract infections. Despite the disease burden, no approved RSV vaccine is available. While...
8.
Lorbetskie B, Bigelow S, Walrond L, Klein A, Loo S, Green N, et al.
J Diabetes Sci Technol
. 2023 Mar;
18(5):1172-1178.
PMID: 36912012
Background: For diabetes mellitus treatment plans, the consistency and quality of insulin drug products are crucial for patient well-being. Because biologic drugs, such as insulin, are complex heterogeneous products, the...
9.
Muralidharan A, Gravel C, Harris G, Hashem A, Zhang W, Safronetz D, et al.
Hum Vaccin Immunother
. 2022 Jun;
18(5):2083428.
PMID: 35724343
Influenza is a major public health concern causing millions of hospitalizations every year. The current vaccines need annual updating based on prediction of likely strains in the upcoming season. However,...
10.
Tamming L, Duque D, Tran A, Zhang W, Pfeifle A, Laryea E, et al.
Front Immunol
. 2022 Jan;
12:785349.
PMID: 35095861
SARS-CoV-2 infections present a tremendous threat to public health. Safe and efficacious vaccines are the most effective means in preventing the infections. A variety of vaccines have demonstrated excellent efficacy...